An Interview with Claus Volko on Symbiont Conversion Theory and More (Part Four)
Author(s): Scott Douglas Jacobsen
Publication (Outlet/Website): In-Sight: Independent Interview-Based Journal
Publication Date (yyyy/mm/dd): 2020/07/01
Abstract
Claus Volko is an Austrian computer and medical scientist who has conducted research on the treatment of cancer and severe mental disorders by conversion of stress hormones into immunity hormones. This research gave birth to a new scientific paradigm which he called “symbiont conversion theory”: methods to convert cells exhibiting parasitic behaviour to cells that act as symbionts. In 2013 Volko, obtained an IQ score of 172 on the Equally Normed Numerical Derivation Test. He is also the founder and president of Prudentia High IQ Society, a society for people with an IQ of 140 or higher, preferably academics. He discusses: Symbiont Conversion Theory; the importance of independent theorizing; what can go wrong without critical scrutiny and peers connected to excessive defensiveness in critical scrutiny of a theory; the “destroy and kill” paradigm; inflammation seen with the Symbiont Conversion Theory; cancer and the “conversion” of systemically negative masses of cancer cells; a practical manifestation; an entirely new scientific paradigm or an adapted and transitional new scientific paradigm; the term symbionts over some other term, even a neologism; the upper limit possibilities in medical applications; inflammation; healthy ways to improve the immune system; Symbiont Conversion Theory; misinterpreted; tumour cells; the general success rate of the current chemotherapy and radiotherapy paradigm of medicine; some other relevant terminology for the re-education of the cells; and some similar ideas in other fields.
Keywords: Claus Volko, destroy and kill, independent theorizing, Symbiont Conversion Theory, tumour cells.
An Interview with Claus Volko on Symbiont Conversion Theory and More (Part Four)[1],[2]*
*Please see the footnotes, bibliography, and citation style listing after the interview.*
1. Scott Douglas Jacobsen: Now, last time we talked, with Rick Rosner, you had a theory: Symbiont Conversion Theory. What is Symbiont Conversion Theory?
Dr. Claus Volko: Symbiont Conversion Theory is a new scientific paradigm. The basic hypothesis is that you do not have to kill cells that display parasitic behaviour but that you can re-educate, or re-program, them to become symbionts. This applies both to cancer and infectious diseases. There have already been publications showing that such a re-programming of bacteria, for example, is possible. I wrote a review article of these publications and proposed the term Symbiont Conversion Theory.
2. Jacobsen: What is the importance of independent theorizing?
Volko: A hypothesis can be called a theory as soon as evidence showing that it is true has been provided. Scientists should come up with many hypotheses, it is the basis of their work.
3. Jacobsen: What can go wrong without critical scrutiny and peers connected to excessive defensiveness in critical scrutiny of a theory?
Volko: As said, a hypothesis is a theory as soon as evidence has been provided. It is possible to falsify a hypothesis by providing counter-examples. That can also be done as soon as the hypothesis has become a theory. In case of Symbiont Conversion Theory, however, this theory is based on an existential statement: It is possible to re-educate parasitic cells. As I told you when we discussed Popper, existential statements cannot be disproven.
4. Jacobsen: Why is the “destroy and kill” paradigm regarding cancer insufficient at the present moment?
Volko: Because of the side-effects chemotherapy and radiotherapy have. They also kill healthy tissue and because they are based on mechanisms that initiate mutations, they can cause cancer themselves.
5. Jacobsen: How is inflammation seen with the Symbiont Conversion Theory?
Volko: Inflammation is a reaction of the immune system that has advantages and disadvantages for the patient. In general, we would like to strengthen the immune system but not by means of inflammation, as it damages tissue.
6. Jacobsen: How would this theory apply to cancer and the “conversion” of systemically negative masses of cancer cells into systemically positive masses of cancer?
Volko: The idea is to reprogram tumour cells so that they do not consume more than other cells and work as functional tissue.
7. Jacobsen: What would be a practical manifestation of this?
Volko: Re-educating parasitic cells instead of killing them would be a revolutionary thing to do. With cancer, it would possibly lead to a cure more often than traditional chemotherapy and radiotherapy.
8. Jacobsen: More precisely, is it an entirely new scientific paradigm or an adapted and transitional new scientific paradigm?
Volko: It is an entirely new scientific paradigm. There has been no paradigm stating that parasites could be educated.
9. Jacobsen: Why use the term symbionts over some other term, even a neologism?
Volko: I use the term symbionts because this is exactly what it is all about: converting parasites into symbionts. While parasites make use of the host organism and have a detrimental effect on it, symbionts live in the state of symbiosis with the host organism so that both sides profit from this symbiosis.
10. Jacobsen: What would be the upper limit possibilities in medical applications for this particular form of treatment involving Symbiont Conversion Theory?
Volko: Probably parasitic and bacterial infections as well as cancer could be treated.
11. Jacobsen: How does inflammation damage tissue?
Volko: At medical school we learn that the stages of inflammation are “rubor, calor, dolor, functio laesa” (these are Latin words). The last term, “functio laesa”, means that the functionality of the tissue gets lost.
12. Jacobsen: What, typically, are normal, healthy ways to improve the immune system?
Volko: Commonly it is recommended to do sports to boost the immune system, and to eat vitamins.
13. Jacobsen: How could Symbiont Conversion Theory be misinterpreted?
Volko: Tumour cells form because of spontaneous mutations. The immune system usually detects these mutations and removes the spurious cells. If the immune system does not succeed in doing so, cancer may arise.
14. Jacobsen: Why do tumour cells form?
Volko: Tumour cells form because of spontaneous mutations. The immune system usually detects these mutations and removes the spurious cells. If the immune system does not succeed in doing so, cancer may arise.
15. Jacobsen: What is the general success rate of the current chemotherapy and radiotherapy paradigm of medicine? Has this been improving or stagnating in its success rate?
Volko: Read about this in medical textbooks. In general, the success rate has been slightly improving because of new treatments, but it is far from being optimal.
16. Jacobsen: What would be some other relevant terminology for the re-education of the cells?
Volko: Some speak of reprogramming.
17. Jacobsen: What are some similar ideas in other fields?
Volko: Harvard Medical School coined the term “Modify and Repair” for the treatment of cancer by converting tumour cells to functional tissue.
Appendix I: Footnotes
[1] Member, World Genius Directory.
[2] Individual Publication Date: July 1, 2020: http://www.in-sightjournal.com/volko-four; Full Issue Publication Date: September 1, 2020: https://in-sightjournal.com/insight-issues/.
License
In-Sight Publishing by Scott Douglas Jacobsen is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. Based on a work at www.in-sightpublishing.com.
Copyright
© Scott Douglas Jacobsen and In-Sight Publishing 2012-Present. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Scott Douglas Jacobsen and In-Sight Publishing with appropriate and specific direction to the original content. All interviewees and authors co-copyright their material and may disseminate for their independent purposes.
In-Sight Publishing 